Item
Ascorbic Acid (ASCORBIC ACID)
Ascorbic Acid with an Assay of 99.0% ~ 100.5%.
White or almost white, crystalline powder or colorless , becoming discolored on exposure to air and moisture.
The Ascorbic Acid we produce is a raw material packed in bulk. The composition is Ascorbic Acid, and specification for Assay is 99.0%-100.5%.
Antioxidant
Attributes
- Gluten-free
- Ingredient declaration
- Kosher
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Applications
- Beverages
- Confections
- Functional Food and Nutrition
- Pet Food
- Prepared Foods
- Other
- Snacks
- Functional Beverages
- Personal Care
- Dietary Supplements/Nutraceuticals
Functions
- Anti-Inflammatory
- Antioxidant
- Flavor
- Preservative
- Sweetener
- Flavor Enhancer
- Digestive Health
- Immune Health
- Sports Nutrition
- Weight Management
- Fat Reduction
Features & benefits
- Conventional
Tags
- beverage
- flavor
- food
- nutraceuticals
- preservative
- vitamins
Locations
| Location name | Address |
|---|---|
| CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | 236 Huanghe Road Shijiazhuang, HE 050035 CHN |
| Luwei Pharmaceutical Group Co., Ltd. | Shuangfeng Industrial Park ZiCHuan District ZiBo CIty, SD 255190 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Allergens.pdf | 8/29/2023 | 8/28/2025 |
| Allergens | Luwei Pharmaceutical Group Co., Ltd. | Allergens.pdf | 10/18/2024 | 10/18/2026 |
| Animal Testing Statement | Luwei Pharmaceutical Group Co., Ltd. | Animal Test Statement.pdf | 1/30/2023 | 1/30/2025 |
| Animal Testing Statement | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Animal Testing Statement.pdf | 1/1/2023 | 12/31/2024 |
| BSE - TSE | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | BSE-TSE Statement.pdf | 3/28/2023 | 3/27/2026 |
| BSE - TSE | Luwei Pharmaceutical Group Co., Ltd. | BSE-TSE Statement.pdf | 5/13/2023 | 5/13/2026 |
| California Prop. 65 | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | CA Prop 65 Statement.pdf | 1/1/2023 | 12/31/2024 |
| California Prop. 65 | Luwei Pharmaceutical Group Co., Ltd. | CA Prop 65.pdf | 5/9/2024 | 5/9/2026 |
| CoA Sample | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | COA.pdf | 4/16/2024 | 4/16/2026 |
| CoA Sample | Luwei Pharmaceutical Group Co., Ltd. | COA.pdf | 10/13/2023 | 10/13/2025 |
| Country of Origin | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Country of Origin.pdf | 8/29/2023 | 8/28/2026 |
| Country of Origin | Luwei Pharmaceutical Group Co., Ltd. | Country of Origin.pdf | 10/18/2024 | 10/18/2027 |
| Dietary Supplement Questionnaire | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Dietary Supplement Questionnaire.pdf | 10/7/2024 | 10/7/2025 |
| Food Contact Packaging Certificate of Compliance | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Food Contact Packaging Cert of Compliance.pdf | 1/1/2023 | 12/31/2024 |
| FSVP Assessment Form | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | FSVP Assessment Form.pdf | 8/15/2024 | 8/15/2025 |
| Gluten | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Gluten.pdf | 2/5/2023 | 2/5/2025 |
| Gluten | Luwei Pharmaceutical Group Co., Ltd. | Gluten.pdf | 12/12/2024 | 12/12/2026 |
| GMO | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | GMO Statement.pdf | 1/1/2024 | 12/31/2025 |
| GMO | Luwei Pharmaceutical Group Co., Ltd. | GMO.pdf | 9/5/2024 | 9/5/2026 |
| GRAS/NDI/ODI Statement | Luwei Pharmaceutical Group Co., Ltd. | GRAS Status Statement.pdf | 3/11/2024 | 3/11/2027 |
| GRAS/NDI/ODI Statement | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | GRAS.pdf | 1/1/2024 | 12/31/2026 |
| HACCP Process Flow Diagram | Luwei Pharmaceutical Group Co., Ltd. | HACCP Flow Chart.pdf | 10/15/2024 | 10/15/2026 |
| HACCP | Luwei Pharmaceutical Group Co., Ltd. | HACCP Plan.pdf | 1/1/2022 | 1/1/2025 |
| HACCP Process Flow Diagram | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | HACCP Process Flowchart.pdf | 8/21/2023 | 8/20/2025 |
| HACCP | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | HACCP Statement.pdf | 1/1/2024 | 12/31/2026 |
| Halal | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | HALAL.pdf | 7/28/2022 | 7/27/2026 |
| Halal | Luwei Pharmaceutical Group Co., Ltd. | Halal.pdf | 11/30/2022 | 11/29/2026 |
| Heavy Metal | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Heavy Metals.pdf | 1/1/2024 | 12/31/2025 |
| Heavy Metal | Luwei Pharmaceutical Group Co., Ltd. | Heavy Metals.pdf | 10/30/2023 | 10/30/2025 |
| Ingredient Statement | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Ingredient Statement.pdf | 5/20/2024 | 5/20/2025 |
| Ingredient Statement | Luwei Pharmaceutical Group Co., Ltd. | Ingredient Statement.pdf | 12/12/2024 | 12/12/2027 |
| EtO Statement | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Irradiation & ETO Statement.pdf | 12/5/2023 | 12/4/2025 |
| Irradiation Status Statement | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Irradiation & ETO Statement.pdf | 1/28/2023 | 1/28/2025 |
| Irradiation Status Statement | Luwei Pharmaceutical Group Co., Ltd. | Irradiation & EtO.pdf | 7/20/2023 | 7/20/2025 |
| Item Questionnaire | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Item Questionnaire.pdf | 8/31/2023 | 8/30/2026 |
| Kosher | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Kosher.pdf | 8/27/2024 | 8/31/2025 |
| Kosher | Luwei Pharmaceutical Group Co., Ltd. | Kosher.pdf | 3/24/2024 | 3/31/2025 |
| Label Sample | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Label Sample.jpeg | 8/31/2023 | 8/31/2025 |
| Lot Code | Luwei Pharmaceutical Group Co., Ltd. | Lot Code Explination.pdf | 4/13/2022 | 4/13/2025 |
| Lot Code | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Lot Code Statement.pdf | 1/1/2024 | 12/31/2026 |
| Melamine | Luwei Pharmaceutical Group Co., Ltd. | Melamine Free Statement.pdf | 7/20/2023 | 7/20/2025 |
| Melamine | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Melamine.pdf | 1/1/2024 | 12/31/2024 |
| National Bioengineered Food Disclosure Standard (Simplified) | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | National Bioengineered Food Disclosure Standard (Simplified).pdf | 9/1/2023 | 8/31/2026 |
| No Animal Ingredient Statement | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | No Animal Ingredient Statement.pdf | 1/1/2024 | 12/31/2024 |
| Nutrition | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Nutrition.pdf | 8/31/2023 | 8/30/2026 |
| Nutrition | Luwei Pharmaceutical Group Co., Ltd. | Nutrition.pdf | 12/9/2024 | 12/9/2027 |
| Pesticide | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Pesticide.pdf | 1/1/2023 | 12/31/2024 |
| Phthalate Esters Letter | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Phthalates.pdf | 1/1/2024 | 12/31/2024 |
| Product Specification Sheet | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Product Spec Sheet.pdf | 5/11/2023 | 5/10/2026 |
| Product Specification Sheet | Luwei Pharmaceutical Group Co., Ltd. | Product Spec Sheet.pdf | 10/1/2023 | 10/1/2026 |
| Residual Statement | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Residual Solvent.pdf | 1/1/2024 | 12/31/2024 |
| Residual Statement | Luwei Pharmaceutical Group Co., Ltd. | Residual Solvents.pdf | 3/21/2024 | 3/21/2025 |
| Safety Data Sheet (SDS) | Luwei Pharmaceutical Group Co., Ltd. | SDS.pdf | 1/1/2024 | 1/1/2026 |
| Sewage Statement | Luwei Pharmaceutical Group Co., Ltd. | Sewage Sludge Statement.pdf | 1/30/2023 | 10/30/2025 |
| Sewage Statement | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Sewage-Sludge.pdf | 1/1/2024 | 12/31/2025 |
| Shelf Life | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Shelf Life.pdf | 1/1/2024 | 12/31/2026 |
| Suitability Requirements | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | Suitability Requirements.pdf | 8/31/2023 | 8/30/2026 |
| Vegan/Vegetarian Statement | Luwei Pharmaceutical Group Co., Ltd. | Vegetarian & Vegan Statement.pdf | 9/23/2023 | 9/22/2025 |
| No Animal Ingredient Statement | Luwei Pharmaceutical Group Co., Ltd. | Vegetarian & Vegan Statement.pdf | 9/23/2023 | 9/23/2025 |
| WADA/NSF/NFL Statement | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | WADA.pdf | 1/1/2024 | 12/31/2025 |
| Safety Data Sheet (SDS) | CSPC Healthcare Inc.- CSPC Weisheng Pharmaceuticals | WS_SDS_Ascorbic Acid.pdf | 8/23/2023 | 8/22/2025 |
-
Documents Up to Date
- 68 locations
- 60 items
- 414 documents